Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TGP Combined With NB-UVB for Sporadic Vitiligo
NCT03608917Completed
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of total glucosides of paeony in Vitiligo (2 arms). Primary endpoint: Vitiligo Area and Severity Index at 24 weeks. Started Apr 2018; status: completed.
02
Drugs
total glucosides of paeony
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03608917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03608917.